171 related articles for article (PubMed ID: 19369534)
1. Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods.
Tapsall J; Read P; Carmody C; Bourne C; Ray S; Limnios A; Sloots T; Whiley D
J Med Microbiol; 2009 May; 58(Pt 5):683-687. PubMed ID: 19369534
[TBL] [Abstract][Full Text] [Related]
2. Four treatment failures of pharyngeal gonorrhoea with ceftriaxone (500 mg) or cefotaxime (500 mg), Sweden, 2013 and 2014.
Golparian D; Ohlsson A; Janson H; Lidbrink P; Richtner T; Ekelund O; Fredlund H; Unemo M
Euro Surveill; 2014 Jul; 19(30):. PubMed ID: 25108533
[TBL] [Abstract][Full Text] [Related]
3. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010.
Unemo M; Golparian D; Hestner A
Euro Surveill; 2011 Feb; 16(6):. PubMed ID: 21329645
[TBL] [Abstract][Full Text] [Related]
4. Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011.
Unemo M; Golparian D; Potočnik M; Jeverica S
Euro Surveill; 2012 Jun; 17(25):. PubMed ID: 22748003
[TBL] [Abstract][Full Text] [Related]
5. Persistence of Neisseria gonorrhoeae DNA following treatment for pharyngeal and rectal gonorrhea is influenced by antibiotic susceptibility and reinfection.
Bissessor M; Whiley DM; Fairley CK; Bradshaw CS; Lee DM; Snow AS; Lahra MM; Hocking JS; Chen MY
Clin Infect Dis; 2015 Feb; 60(4):557-63. PubMed ID: 25371490
[TBL] [Abstract][Full Text] [Related]
6. Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia.
Y Chen M; Stevens K; Tideman R; Zaia A; Tomita T; Fairley CK; Lahra M; Whiley D; Hogg G
J Antimicrob Chemother; 2013 Jun; 68(6):1445-7. PubMed ID: 23390207
[No Abstract] [Full Text] [Related]
7. Incidence and treatment outcomes of pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections in men who have sex with men: a 13-year retrospective cohort study.
Ota KV; Fisman DN; Tamari IE; Smieja M; Ng LK; Jones KE; Diprima A; Richardson SE
Clin Infect Dis; 2009 May; 48(9):1237-43. PubMed ID: 19323630
[TBL] [Abstract][Full Text] [Related]
8. An audit of pharyngeal gonorrhoea treatment in a public sexual health clinic in Adelaide, South Australia.
Hustig A; Bell C; Waddell R
Int J STD AIDS; 2013 May; 24(5):399-400. PubMed ID: 23970709
[TBL] [Abstract][Full Text] [Related]
9. Should urologists care for the pharyngeal infection of Neisseria gonorrhoeae or Chlamydia trachomatis when we treat male urethritis?
Hamasuna R; Takahashi S; Uehara S; Matsumoto T
J Infect Chemother; 2012 Jun; 18(3):410-3. PubMed ID: 22302695
[TBL] [Abstract][Full Text] [Related]
10. Persistence after treatment of pharyngeal gonococcal infections in patients of the STI clinic, Amsterdam, the Netherlands, 2012-2015: a retrospective cohort study.
Hananta IPY; De Vries HJC; van Dam AP; van Rooijen MS; Soebono H; Schim van der Loeff MF
Sex Transm Infect; 2017 Nov; 93(7):467-471. PubMed ID: 28822976
[TBL] [Abstract][Full Text] [Related]
11. Isolated pharyngeal Neisseria gonorrhoeae in heterosexual male contacts.
Thomson-Glover R; Brown R; Edirisinghe DN
Int J STD AIDS; 2013 Dec; 24(12):983-5. PubMed ID: 23970625
[TBL] [Abstract][Full Text] [Related]
12. Single dose 1 g ceftriaxone for urogenital and pharyngeal infection caused by Neisseria gonorrhoeae.
Muratani T; Inatomi H; Ando Y; Kawai S; Akasaka S; Matsumoto T
Int J Urol; 2008 Sep; 15(9):837-42. PubMed ID: 18665871
[TBL] [Abstract][Full Text] [Related]
13. One confirmed and one suspected case of pharyngeal gonorrhoea treatment failure following 500mg ceftriaxone in Sydney, Australia.
Read PJ; Limnios EA; McNulty A; Whiley D; Lahra MM
Sex Health; 2013 Nov; 10(5):460-2. PubMed ID: 24028864
[TBL] [Abstract][Full Text] [Related]
14. Retrospective review of pharyngeal gonorrhea treatment failures in Alberta, Canada.
Gratrix J; Bergman J; Egan C; Drews SJ; Read R; Singh AE
Sex Transm Dis; 2013 Nov; 40(11):877-9. PubMed ID: 24113412
[TBL] [Abstract][Full Text] [Related]
15. Trends in antimicrobial susceptibility for azithromycin and ceftriaxone in Neisseria gonorrhoeae isolates in Amsterdam, the Netherlands, between 2012 and 2015.
Wind CM; Schim van der Loeff MF; van Dam AP; de Vries HJ; van der Helm JJ
Euro Surveill; 2017 Jan; 22(1):. PubMed ID: 28079519
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure.
Lewis DA; Sriruttan C; Müller EE; Golparian D; Gumede L; Fick D; de Wet J; Maseko V; Coetzee J; Unemo M
J Antimicrob Chemother; 2013 Jun; 68(6):1267-70. PubMed ID: 23416957
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of pharyngeal Chlamydia trachomatis and Neisseria gonorrhoeae among heterosexual men in Japan.
Wada K; Uehara S; Mitsuhata R; Kariyama R; Nose H; Sako S; Ishii A; Watanabe T; Matsumoto A; Monden K; Uno S; Araki T; Kumon H
J Infect Chemother; 2012 Oct; 18(5):729-33. PubMed ID: 22491994
[TBL] [Abstract][Full Text] [Related]
18. Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial.
Ross JDC; Brittain C; Cole M; Dewsnap C; Harding J; Hepburn T; Jackson L; Keogh M; Lawrence T; Montgomery AA; Roberts TE; Sprange K; Tan W; Thandi S; White J; Wilson J; Duley L;
Lancet; 2019 Jun; 393(10190):2511-2520. PubMed ID: 31056291
[TBL] [Abstract][Full Text] [Related]
19. Multicenter, comparative study of enoxacin and ceftriaxone for treatment of uncomplicated gonorrhea.
Pabst KM; Siegel NA; Smith S; Black JR; Handsfield HH; Hook EW
Sex Transm Dis; 1989; 16(3):148-51. PubMed ID: 2510329
[TBL] [Abstract][Full Text] [Related]
20. Multiple doses of cefodizime are necessary for the treatment of Neisseria gonorrhoeae pharyngeal infection.
Matsumoto T; Muratani T; Takahashi K; Ikuyama T; Yokoo D; Ando Y; Sato Y; Kurashima M; Shimokawa H; Yanai S
J Infect Chemother; 2006 Jun; 12(3):145-7. PubMed ID: 16826347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
